Entheon Biomedical Corp. (ENTBF)
- Previous Close
0.0943 - Open
0.0943 - Bid 0.0546 x --
- Ask 0.1179 x --
- Day's Range
0.0943 - 0.0943 - 52 Week Range
0.0040 - 0.2000 - Volume
146 - Avg. Volume
487 - Market Cap (intraday)
889,105 - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Oct 23, 2024 - Oct 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.
www.entheonbiomedical.comRecent News: ENTBF
View MorePerformance Overview: ENTBF
Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENTBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENTBF
View MoreValuation Measures
Market Cap
898.46k
Enterprise Value
681.76k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.39
Price/Book (mrq)
1.60
Enterprise Value/Revenue
4.88
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-48.64%
Return on Equity (ttm)
-86.71%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-337.8k
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
299.14k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-238.74k